Johnson L.Hyperbilirubinemia in the term infant: when to worry, when to treat . NY State J Med.1991;91:483-489.
2.
Maisels MJ, Newman TBKernicterus occurs in fullterm healthy newborns without apparent hemolysis . Pediatr Res.1994;35:239A. Abstract.
3.
Penn A., Enzmann D., Hahn J., Stevenson D.Kernicterus in a full term infant. Pediatrics. 1994. In press.
4.
Diamond LK, Allen Fhj, Thomas Woj.Erythroblastosis fetalis. VII. Treatment with exchange transfusion . N Engl J Med.1951;244:39.
5.
Connolly AM, Volpe JJClinical features of bilirubin encephalopathy. Clin Perinatol.1990;17:371-379.
6.
Hsia Dy-YAllen FH, Diamond LK, Gellis SSErythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med.1952;247:668.
7.
Mollison PL, Cutbush M.Haemolytic disease of the newborn. In: Gairndner D, ed. RecentAdvances in Pediatrics. New York, NY: Blakiston and Son Co; 1954:110-135.
8.
Dikshit SK, Gupta PKExchange transfusion in neonatal hyperbilirubinemia. Indian Pediatr.1989;26:1139-1145.
9.
Cremer RJ, Perryman PW, Richards DHInfluence of light on the hyperbilirubinaemia of infants. Lancet. 1958;1:1094-1097.
10.
Scheidt PC, Bryla DA, Nelson KB, et al. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial . Pediatrics. 1990;85:455-463.
11.
Oh W., Karecki H.Phototherapy and insensible water loss in the newborn infant. AmJDis Child.1972;124:230-233.
12.
Freda VJ, Gorman JG, Polack W.Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma-2-globulin antibody preparation: a preliminary report. Transfusion. 1964;4:26-31.
13.
Freda VJ, Gorman JG, Pollack W., et al. Prevention of Rh hemolytic disease — 10 year clinical experience with Rh immune globulin. N Engl J Med.1975;292:1014-1017.
14.
Ennever JF, Dresing TJQuantum yields for the cyclization and configurational isomerization of 4E,15Z-bilirubin . Photochem Photobiol. 1991;53:25-32.
15.
Gale R., Dranitzki Z., Dollberg S., Stevenson DKA randomized, controlled application of the Wallaby phototherapy system compared with standard phototherapy. J Perinatol.1990 ;10:239-242.
16.
Grunebaum E. , Amir J., Merlob P., et al. Breast milk jaundice: natural history, familial incidence and late neurodevelopmental outcome of the infant . Eur J Pediatr.1991;150:267-270.
Newman TB, Maisels MJDoes hyperbilirubinemia damage the brain of healthy full-term infants?Clin Perinatol.1990;17:331-358.
19.
Gartner L.Personal communication.
20.
Gartner L., Lee K.Jaundice and liver disease. In: Fannaroff A, Martin R, eds. Neonatal-Perinatal Medicine. Disease of the Fetus and Infant. St. Louis, MO : Mosby; 1992:1092-1098 (vol 2).
21.
Maisels MJNeonatal jaundice. In: Avery GB, ed. Neonatology. Pathophysiology and Management of the Newborn. 3rd ed. Philadelphia, PA: JB Lippincott Co; 1987:534-629.
22.
Alhfors CECriteria for exchange transfusion in jaundiced newborns. Pediatrics. 1994;93:488-494.
23.
McDonagh AFIs bilirubin good for you?Clin Perinatol.1990;17:359-369.
24.
Stocker R., McDonagh AF, Glazer AN, Ames BNAntioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol.1990;186:301-309.
25.
Stocker R., Yamamoto Y., McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance . Science. 1987;235:1043-1046.
26.
Dennery PA, McDonagh AF, Stevenson DKIn vivo role of bilirubin in neonatal antioxidant defenses. Pediatr Res.1992;31:A200. Abstract.
27.
Hegyi T., Goldie E., Hiatt M.The protective role of bilirubin in oxygen-radical diseases of the preterm infant. J Perinatol.1994;14:296-300.
28.
Aruoma OI, Evans PJ, Kaur H., et al. An evaluation of the antioxidant and potential pro-oxidant properties of food additives and of trolox C, vitamin E and probucol. Free Radic Res Commun.1990;10:143-157.
29.
Nelson SK, Bose SK, McCord JM. The toxicity of high dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart . Free Rad Biol Med.1994 ;16:195-200.
30.
Ochoa EL, Wennberg RP, An Y., et al. Interactions of bilirubin with isolated presynaptic nerve terminals: functional effects on the uptake and release of neurotransmitters. Cell Mol Neurobiol. 1993;13:69-86.
31.
Rhine W., Schmitter S., Yu A., et al. The effects of bilirubin in primary cultures of astrocytes. Pediatr Res.1992;31:219A. Abstract.
32.
Amit Y., Cashore W., Schiff D.Studies of bilirubin toxicity at the synaptosome and cellular levels . Semin Perinatol.1992;16:186-190.
33.
Bratlid D.How bilirubin gets into the brain. Clin Perinatol.1990;17:449-465.
34.
Turkel SBAutopsy findings associated with neonatal hyperbilirubinemia. Clin Perinatol.1990;17:381-396.
35.
Brann BS, Stonestreet BS, Oh W., Cashore WJThe in vivo effect of bilirubin and sulfisoxazole on cerebral oxygen, glucose, and lactate metabolism in newborn piglets. Pediatr Res.1987;22:135-140.
36.
Brodersen R. , Stern L.Deposition of bilirubin acid in the central nervous system — a hypothesis for the development of kernicterus . Acta Paediatr Scand.1990;79:12-19.
37.
Ennever JF, Costarino AT, Polin RA, Speck WTRapid clearance of a structural isomer of bilirubin during phototherapy . J Clin Invest.1987;79:1674-1678.
38.
Rodgers PA, Vreman HJ, Dennery PA, Stevenson DKSources of carbon monoxide (CO) in biological systems and applications of CO detection technologies. Semin Perinatol.1994;18:2-10.
39.
Howson CP, Fineberg HVThe ricochet of magic bullets: summary of the Institute of Medicine report, adverse effects of pertussis and rubella vaccines. Pediatrics.1992;89:318-323.
40.
Loughnan PM , McDougall PN. The efficacy of oral vitamin K1: implications for future prophylaxis to prevent haemorrhagic disease of the newborn. J Paediatr Child Health.1993 ;29:171-176.